Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $103.97 ($7.3M) on 2015-04-15, disclosed to the SEC on 2015-04-17.
Scheduled sale ($7.3M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.06 | 10,239 | $1.1M | 14.5% |
| 2 | $103.97 | 59,761 | $6.2M | 85.5% |
| Total | $103.84 avg | 70,000 | $7.3M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |